ArticlePatient preference and adherence2025
Characteristics and Related Factors of Chinese Herbal Medicine Use in Middle-Aged and Older Patients with Cardiovascular Disease in China: A Cross-Sectional Study.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors associated with Traditional Chinese Medicine use among older adults with chronic diseases in China.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular disease (CVD) poses a significant health burden in middle-aged and older Chinese populations, with Chinese herbal medicine (CHM) often used as a complementary therapy. This study aimed to analyze the characteristics of CHM use and its influencing factors in middle-aged and older Chinese patients with CVD. Methods: This was a cross-sectional study based on data from the 2018 China Health and Aging Longitudinal Study (CHARLS). We surveyed 4511 patients with CVD, aged 45 years or older, who reported using CHM to analyze their demographic characteristics, healthcare utilization, and health status. Results: Approximately 24.05% (1085/4511) of the participants reported managing CVD with CHM. Compared with non-users, CHM users were older (OR=1.21; 95% CI=1.04-1.40), more educated (OR=1.30; 95% CI=1.08-1.57), more likely to reside in a city (OR=1.19; 95% CI=1.01-1.41), and were associated with visiting a Chinese medicine hospital (OR=1.17; 95% CI=1.01-1.37), self-medication (OR=1.48; 95% CI=1.24-1.77), poor health (OR=1.52; 95% CI=1.17-1.98), comorbidities such as kidney disease (OR=1.34; 95% CI=1.02-1.75), asthma (OR=1.67; 95% CI=1.21-2.32), and emotional problems (OR=1.98; 95% CI=1.28-3.07). In an additional interaction analysis, patients with urban residence and mood problems were most likely to use CHM (OR=6.93, 95% CI: 1.77-27.19). Conclusion: Factors contributing to CHM use in middle-aged and older patients with CVD are multifaceted, encompassing demographic characteristics, health service, and health status.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.